A sensitive ELISA for glial fibrillary acidic protein: application in CSF of adults

https://doi.org/10.1016/0165-0270(94)90011-6Get rights and content

Abstract

The present study concerns an ELISA for glial fibrillary acidic protein (GFAP) in cerebrospinal fluid (CSF). The application of the method in CSF of children has previously been described in this journal. We have now adapted the technique to allow determination of the much higher GFAP concentrations found in normal and pathological CSF of adults. The assay range was extended to 16,000 pg/ml. CSF levels as high as 170,000 pg/ml could be assayed since dilution experiments indicated immunological identity between purified GFAP and GFAP in CSF. In normal controls the concentrations correlated significantly with age (P < 0.001, Spearman rank correlation test). The concentrations were less than 200 pg/ml before 20 years of age and increased to between 500 and 1300 pg/ml at approximately 75 years of age. This increase of CSF GFAP probably reflects formation of astroglial filaments in the CNS and it must be taken into consideration when determining the pathological CSF GFAP level. The method was validated using CSF samples from patients with either astrogliosis or acute tissue destruction in the CNS. Although augmented levels were observed in both groups it is quite clear that patients with acute tissue destruction may display very high CSF GFAP concentrations, whereas levels in patients with astrogliosis were only modestly increased if at all.

References (48)

  • B. Karlsson et al.

    Radioimmunoassay of myelin basic protein

  • F. Michetti et al.

    The S-100 antigen in cerebrospinal fluid as a possible index of cell injury in the nervous system

    J. Neurol. Sci.

    (1980)
  • K. Mokuno et al.

    Neuron-specific enolase and S-100 levels in cerebrospinal fluid of patients with various neurological diseases

    J. Neurol. Sci.

    (1983)
  • M. Noppe et al.

    A two-site immunoradiometric assay for the determination of α-albumin

    J. Immunol. Methods

    (1979)
  • M. Noppe et al.

    Determination in human cerebrospinal fluid of glial fibrillary acidic protein, S-100 and myelin basic protein as indices of non-specific or specific central nervous tissue pathology

    Clin. Chim. Acta

    (1986)
  • J.P. O'Callaghan et al.

    The concentration of glial fibrillary acidic protein increases with age in the mouse brain

    Neurobiol. Aging

    (1991)
  • L.E. Rosengren et al.

    A sensitive ELISA for glial fibrillary acidic protein: application in CSF of children

    J. Neurosci. Methods

    (1992)
  • D.C. Rueger et al.

    Formation of 100 Å filaments from purified glial fibrillary acidic protein in vitro

    J. Mol. Biol.

    (1979)
  • M. Steinbuch et al.

    The isolation of IgG from mammalian sera with the aid of caprylic acid

    Arch. Biochem. Biophys.

    (1969)
  • M. Albrechtsen et al.

    Enzyme-linked immunosorbent assay for the human glial fibrillary acidic protein using a mouse monoclonal antibody

    J. Neurochem.

    (1985)
  • American Psychiatric Association

    Diagnosis and Statistical Manual of Mental Disorders

    (1987)
  • A. Aurell et al.

    Determination of S-100 and GFA protein concentrations in cerebrospinal fluid after brain infarction

    Stroke

    (1991)
  • A. Bignami et al.

    The astroglial response to stabbing

  • R. Crols et al.

    Increased GFAp levels in CSF as a marker of organicity in patients with Alzheimer's disease and other types of irreversible chronic organic brain syndrome

    J. Neurol.

    (1986)
  • Cited by (168)

    View all citing articles on Scopus
    View full text